AAAAAA

   
Results: 1-10 |
Results: 10
Pharmacotherapy of social anxiety disorder: an algorithm for primary care-2001
Authors: Stein, DJ Kasper, S Matsunaga, H Osser, DN Stein, MB Van Ameringen, M Versiani, M Westenberg, H Zhang, MY
Citation: Dj. Stein et al., Pharmacotherapy of social anxiety disorder: an algorithm for primary care-2001, PRIM CARE P, 7(3), 2001, pp. 107-110
The selective noradrenaline re-uptake inhibitor reboxetine has an early onset of antidepressant action
Authors: Versiani, M
Citation: M. Versiani, The selective noradrenaline re-uptake inhibitor reboxetine has an early onset of antidepressant action, INT J PSYC, 4(4), 2000, pp. 293-297
Reboxetine, the first selective noradrenaline reuptake inhibitor antidepressant: Efficacy and tolerability in 2613 patients
Authors: Versiani, M
Citation: M. Versiani, Reboxetine, the first selective noradrenaline reuptake inhibitor antidepressant: Efficacy and tolerability in 2613 patients, INT J PSYC, 4(3), 2000, pp. 201-208
Sudden remission of obsessive-compulsive disorder by involuntary, massive exposure
Authors: Fontenelle, L Soares, ID Marques, C Range, B Mendlowicz, MV Versiani, M
Citation: L. Fontenelle et al., Sudden remission of obsessive-compulsive disorder by involuntary, massive exposure, CAN J PSY, 45(7), 2000, pp. 666-667
Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorder
Authors: Versiani, M Amin, M Chouinard, G
Citation: M. Versiani et al., Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorder, J CL PSYCH, 20(1), 2000, pp. 28-34
Social functioning in depression: A review
Authors: Hirschfeld, RMA Montgomery, SA Keller, MB Kasper, S Schatzberg, AF Moller, HJ Healy, D Baldwin, D Humble, M Versiani, M Montenegro, R Bourgeois, M
Citation: Rma. Hirschfeld et al., Social functioning in depression: A review, J CLIN PSY, 61(4), 2000, pp. 268-275
Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison
Authors: Versiani, M Ontiveros, A Mazzotti, G Ospina, J Davila, J Mata, S Pacheco, A Plewes, J Tamura, R Palacios, M
Citation: M. Versiani et al., Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison, INT CLIN PS, 14(6), 1999, pp. 321-327
Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial
Authors: Katona, C Bercoff, E Chiu, E Tack, P Versiani, M Woelk, H
Citation: C. Katona et al., Reboxetine versus imipramine in the treatment of elderly patients with depressive disorders: a double-blind randomised trial, J AFFECT D, 55(2-3), 1999, pp. 203-213
Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder
Authors: Versiani, M Mehilane, L Gaszner, P Arnaud-Castiglioni, R
Citation: M. Versiani et al., Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder, J CLIN PSY, 60(6), 1999, pp. 400-406
Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide
Authors: Versiani, M
Citation: M. Versiani, Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide, J AFFECT D, 51(3), 1998, pp. 323-332
Risultati: 1-10 |